Physician profile
Timothy A Spence
NPI 1528030251
$2,062.77
in general payments reported to CMS, 2019-2025
21 companies · $83.71 in 2025
The $83.71 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $129 · 2021: $522 · 2022: $457 · 2023: $141 · 2024: $529 · 2025: $83.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $477.88 | 2021-2025 | Qelbree |
| Sanofi-Aventis U.S. LLC | $211.22 | 2024 | |
| Glaxosmithkline, LLC. | $197.27 | 2021-2025 | Bexsero |
| Sobi, INC | $143.01 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $141.84 | 2021-2022 | |
| Abbvie INC. | $141.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $122.09 | 2021-2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $82.76 | 2020-2025 | |
| Adlon Therapeutics L.P. | $76.37 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $63.70 | 2019-2021 | |
| Corium, LLC | $59.85 | 2021-2025 | Azstarys |
| Sanofi Pasteur INC. | $54.64 | 2021-2024 | |
| Tris Pharma INC | $52.68 | 2021-2022 | |
| Seqirus USA INC | $50.33 | 2020-2024 | Flucelvax, Flucelvax Quadrivalent |
| Cranial Technologies, INC | $44.98 | 2020-2023 | Doc Band |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $39.57 | 2019-2020 | |
| Rhythm Pharmaceuticals, INC. | $24.24 | 2024 | Imcivree |
| Baxter Healthcare | $21.80 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.64 | 2022 | |
| Vertical Pharmaceuticals, LLC | $18.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Spence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.